AL
CHGG icon

Aspiriant LLC’s Chegg CHGG Stock Holding History

Aspiriant LLC’s Portfolio CHGG Stock Details CHGG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,000
Closed -$169K – 213
2017
Q1 		$169K Buy
+20,000
New +$154K 0.01% 205

Other funds holding CHGG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SCH
Sylebra Capital (HK) Hong Kong $1.88B AUM 19.75% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Aspiriant LLC's CHGG Position: Q2 2017 in Review

Aspiriant LLC sold out of Chegg (CHGG) in Q2 2017, closing a stake of 20,000 shares — an estimated $169K sold.

Aspiriant LLC first reported a position in CHGG in Q1 2017 and held it in 1 quarter. The position peaked at $169K in Q1 2017. 157 funds tracked by Wall St. Rank hold CHGG as of Q2 2017.

  • Aspiriant LLC reported no remaining Chegg position as of Q2 2017 after selling out during the quarter.
  • Aspiriant LLC sold 20,000 Chegg shares in Q2 2017, an estimated $169K.
  • Aspiriant LLC first reported a position in Chegg in Q1 2017 and held it in 1 quarter.
  • Aspiriant LLC's Chegg position peaked at $169K in Q1 2017.
  • 157 funds tracked by Wall St. Rank held Chegg as of Q2 2017.

Based on Aspiriant LLC's 13F filing for Q2 2017, filed 3 Aug 2017.